Tandem Mobi System Tandem Mobi + Android is here!
Note: Adhesive sleeve sold separately.
Control-IQ+ Technology
Tandem Mobi System
This insulin pump can be worn almost anywhere,* giving you more options for how you manage your diabetes. It’s powered by Control-IQ+ technology and is controllable with a compatible, personal smartphone.†
t:slim X2 Insulin Pump
This all-in-one system features a slim, sleek, user-friendly color touchscreen and multiple CGM options.‡ It’s powered by Control-IQ+ technology, which predicts and helps prevent highs and lows.
Hear from parents, kids, and teens who have experienced the life‑changing benefits of Tandem automated insulin delivery.
My A1c has been amazing since I switched to Tandem. I used to wake up with lows, and that’s really scary. But Tandem is my safety net.
Izzy
diagnosed 2016
Tristan
diagnosed 1997
Kim
Mother to Anna, diagnosed 2020
Eva
diagnosed 2015
Individual symptoms, situations, circumstances, and results may vary.
Choose from a variety of cannula materials, tubing lengths, and insertion angles to fit your needs.
Technology evolves at a rapid pace. That’s why our insulin pumps are capable of remote software updates.
Our mobile and cloud-based applications are designed to help you better manage your diabetes.
Our Support Team (available 24 hours a day, 365 days a year) is staffed by highly trained representatives.
We offer personal pump training to new customers so they can quickly learn our easy-to-use products.
We’re there for you! We can replace your insulin pump to minimize any disruption to your insulin therapy.§
An insulin pump, like a healthy pancreas, delivers one type of insulin. You can use personalized settings on your insulin pump to deliver insulin continuously (basal) or in larger doses for meals (bolus).
What's next?
Whether you're ready to get a Tandem insulin pump, or looking to check insurance coverage, you’ll find everything you need here.
* Do not wear or place your pump more than 12 inches (30.5 cm) above your infusion site. Doing so may result in over delivery of insulin.
† The mobile app requires a compatible smartphone model and operating system (sold separately). Only available to pump users who reside in the United States.
‡ CGM sold separately.
§ See warranty terms and conditions for more details at tandemdiabetes.com/legal/warranty.
Reference
Note: Study was conducted using a t:slim X2 insulin pump with Control-IQ technology and Dexcom G6 sensor.
1. Beck RW, et al. Diabetes Technol Ther. 2023;25(5):329-342.
Important Safety Information
RX ONLY.
Indications for Use
Tandem Mobi system: The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.
t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.
Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ+ technology is intended for the management of type 1 diabetes mellitus in persons 2 years of age and greater and of type 2 diabetes mellitus in persons 18 years of age and greater.
Warning: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds (9 kilograms), as those are the required minimum values needed for Control-IQ+ to operate safely.
Users of the pump and Control-IQ+ must: use the insulin pump, iCGM, and all other system components in accordance with their respective instructions for use. Failure to follow these instructions for use could result in an over delivery or under delivery of insulin. This can cause hypoglycemia (low BG) or hyperglycemia (high BG) events. Visit tandemdiabetes.com/safetyinfo for additional important safety information.
FreeStyle Libre 3 Plus sensor: For FreeStyle Libre 3 Plus sensor safety information, please visit freestyle.abbott/us-en/safety-information. The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission.